Denali Therapeutics Inc. (DNLI)
$19.45+4.18%Close
SELLCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.1B
- Beta
- 1.02
- P/E (TTM)
- -6.79
- Short % float
- 10.72%
- Days to cover
- 7.6
- SI change
- -9.8%
- 1W
- -2.75%
- 1M
- -9.11%
- vs SPY 1W
- -3.91%
- vs SPY 1M
- -12.10%
Industry peers
FMP comparable companies · ranked by market cap
- IBRXBUYImmunityBio, Inc.$10.8BRECOVERYQ 8$10.29+6.05%
- COGTSELLCogent Biosciences, Inc.$5.3BRECOVERYQ 13$31.02+3.06%
- RCUSSELLArcus Biosciences, Inc.$3.1BRECOVERYQ 17$24.44+2.43%
- LQDASELLLiquidia Corporation$2.5BCRISISQ 12$28.64-2.28%
- BEAMBUYBeam Therapeutics Inc.$2.5BRECOVERYQ 14$24.50+4.47%
- ETNB89bio, Inc.$2.2B$14.84
- VRDNSELLViridian Therapeutics, Inc.$2.2BCRISISQ -3$19.40+1.74%
- RXRXBUYRecursion Pharmaceuticals, Inc.$2.2BRECOVERYQ 1$4.12+10.38%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.80-0.34%
- GLPGGalapagos N.V.$1.8B$27.98
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
